ClinicalTrials.gg
Drug

Tusamitamab ravtansine clinical trials

Also written SAR408701.

studies test it
11
open now
0
in phase 3
1
first study started
2014

How each study uses tusamitamab ravtansine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Tusamitamab ravtansine
6

Development codes

SAR408701
8

Studies by the year they started

11 studies that test it; most in 2020 (3)

Studies that test tusamitamab ravtansine, by start year
YearStudies
20141
20171
20203
20212
20222
20231
20241

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
7
Phase 3
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 10 · Other 1

Sanofi (9) · Innovent Biologics (Suzhou) Co. Ltd. (1) · Erasmus Medical Center (1)

Often tested with

Tested in the same studies.

Sintilimab (1)

Studies

Open first, then newest update. How each study uses tusamitamab ravtansine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 11

Codes

What other systems call tusamitamab ravtansine · ClinicalTrials.gg INT001749

  • MeSH (NLM) C000720449tusamitamab ravtansineConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) DSS3BE2ZXNTUSAMITAMAB RAVTANSINEConfirmed FDA, NLM
  • NCI Thesaurus C117229Tusamitamab RavtansineOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.